Medizinische Universität Graz - Research portal
Kraßnig Stefanie |
** = Publications listed in SCI/SSCI/Pubmed
2023
Full paper/article (Journal)
** Alcaniz, J; Winkler, L; Dahlmann, M; Becker, M; Orthmann, A; Haybaeck, J; Krassnig, S; Skofler, C; Kratzsch, T; Kuhn, SA; Jödicke, A; Linnebacher, M; Fichtner, I; Walther, W; Hoffmann, J
Clinically relevant glioblastoma patient-derived xenograft models to guide drug development and identify molecular signatures.
Front Oncol. 2023; 13:1129627
Doi: 10.3389/fonc.2023.1129627
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Krassnig, S; Leber, SL; Orthmann, A; Golob-Schwarzl, N; Huber, HJ; Wohlrab, C; Skofler, C; Pennauer, M; Raicht, A; Birkl-Toeglhofer, AM; Naumann, M; Mahdy-Ali, K; von, Campe, G; Leoni, M; Alcaniz, J; Hoffmann, J; Wälchli, T; Weis, S; Benesch, M; Haybaeck, J
Decreased eukaryotic initiation factors expression upon temozolomide treatment-potential novel implications for eIFs in glioma therapy.
J Neurooncol. 2023; 165(1):91-100
Doi: 10.1007/s11060-023-04451-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Correction
** Golob-Schwarzl, N; Schweiger, C; Koller, C; Krassnig, S; Gogg-Kamerer, M; Gantenbein, N; Toeglhofer, AM; Wodlej, C; Bergler, H; Pertschy, B; Uranitsch, S; Holter, M; El-Heliebi, A; Fuchs, J; Punschart, A; Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Reinhard, C; Regenbrecht, C; Schicho, R; Fickert, P; Lax, S; Haybaeck, J
Correction: Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6.
Oncotarget. 2023; 14: 83-84.
Doi: 10.18632/oncotarget.28115
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
2022
Abstract (Journal)
** Alcaniz, J; Dahlmann, M; Conrad, T; Orthmann, A; Haybaeck, J; Krassnig, S; Wodlej, C; Birkl-Toeglhofer, AM; Kratzsch, T; Kuhn, SA; Joedicke, A; Iduna, F; Hoffmann, J; Walther, W
Molecular analyses of Glioblastoma patient-derived xenograft (PDX) models identify potential targets in treatment resistant tumors
ONCOL RES TREAT. Abstracts 35. Deutscher Krebskongress. 2022; 45(SUPPL 3):47-47.-35. Deutscher Krebskongress. Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung; NOV 13-16, 2022; Berlin, GERMANY.
[Poster]
Web of Science
2021
Full paper/article (Journal)
** Krassnig, S; Wohlrab, C; Golob-Schwarzl, N; Raicht, A; Schatz, C; Birkl-Toeglhofer, AM; Skofler, C; Gantenbein, N; Leoni, M; Asslaber, M; Leber, SL; Mahdy-Ali, K; von Campe, G; Mayer, M; Borenich, A; Weis, S; Benesch, M; Haybaeck, J
A Profound Basic Characterization of eIFs in Gliomas: Identifying eIF3I and 4H as Potential Novel Target Candidates in Glioma Therapy.
Cancers (Basel). 2021; 13(6):
Doi: 10.3390/cancers13061482
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Skofler, C; Kleinegger, F; Krassnig, S; Birkl-Toeglhofer, AM; Singer, G; Till, H; Benesch, M; Cencic, R; Porco, JA; Pelletier, J; Castellani, C; Raicht, A; Izycka-Swieszewska, E; Czapiewski, P; Haybaeck, J
Eukaryotic Translation Initiation Factor 4AI: A Potential Novel Target in Neuroblastoma.
Cells. 2021; 10(2):
Doi: 10.3390/cells10020301
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2020
Correction
** Golob-Schwarzl, N; Bettermann, K; Mehta, AK; Kessler, SM; Unterluggauer, J; Krassnig, S; Kojima, K; Chen, X; Hoshida, Y; Bardeesy, NM; Müller, H; Svendova, V; Schimek, MG; Diwoky, C; Lipfert, A; Mahajan, V; Stumptner, C; Thüringer, A; Fröhlich, LF; Stojakovic, T; Nilsson, KPR; Kolbe, T; Rülicke, T; Magin, TM; Strnad, P; Kiemer, AK; Moriggl, R; Haybaeck, J
Corrigendum to High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer Phenotype12 [Translational Oncology Volume 12, Issue 2, February 2019, Pages 256-268].
Transl Oncol. 2020; 13(2):490-492
Doi: 10.1016/j.tranon.2019.08.001
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2019
Full paper/article (Journal)
** Golob-Schwarzl, N; Bettermann, K; Mehta, AK; Kessler, SM; Unterluggauer, J; Krassnig, S; Kojima, K; Chen, X; Hoshida, Y; Bardeesy, NM; Müller, H; Svendova, V; Schimek, MG; Diwoky, C; Lipfert, A; Mahajan, V; Stumptner, C; Thüringer, A; Fröhlich, LF; Stojakovic, T; Nilsson, KPR; Kolbe, T; Rülicke, T; Magin, TM; Strnad, P; Kiemer, AK; Moriggl, R; Haybaeck, J
High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer Phenotype.
Transl Oncol. 2019; 12(2):256-268
Doi: 10.1016/j.tranon.2018.10.010
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kleinegger, F; Hofer, E; Wodlej, C; Golob-Schwarzl, N; Birkl-Toeglhofer, AM; Stallinger, A; Petzold, J; Orlova, A; Krassnig, S; Reihs, R; Niedrist, T; Mangge, H; Park, YN; Thalhammer, M; Aigelsreiter, A; Lax, S; Garbers, C; Fickert, P; Rose-John, S; Moriggl, R; Rinner, B; Haybaeck, J
Pharmacologic IL-6Rα inhibition in cholangiocarcinoma promotes cancer cell growth and survival.
Biochim Biophys Acta Mol Basis Dis. 2019; 1865(2):308-321
Doi: 10.1016/j.bbadis.2018.11.006
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wernitznig, S; Reichmann, F; Sele, M; Birkl, C; Haybäck, J; Kleinegger, F; Birkl-Töglhofer, A; Krassnig, S; Wodlej, C; Holzer, P; Kummer, D; Bock, E; Leitinger, G
An Unbiased Approach of Sampling TEM Sections in Neuroscience.
J Vis Exp. 2019; (146):
Doi: 10.3791/58745
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2018
Full paper/article (Journal)
** Birkl, C; Soellradl, M; Toeglhofer, AM; Krassnig, S; Leoni, M; Pirpamer, L; Vorauer, T; Krenn, H; Haybaeck, J; Fazekas, F; Ropele, S; Langkammer, C
Effects of concentration and vendor specific composition of formalin on postmortem MRI of the human brain.
Magn Reson Med. 2018; 79(2):1111-1115
Doi: 10.1002/mrm.26699
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gantenbein, N; Bernhart, E; Anders, I; Golob-Schwarzl, N; Krassnig, S; Wodlej, C; Brcic, L; Lindenmann, J; Fink-Neuboeck, N; Gollowitsch, F; Stacher-Priehse, E; Asslaber, M; Gogg-Kamerer, M; Rolff, J; Hoffmann, J; Silvestri, A; Regenbrecht, C; Reinhard, C; Pehserl, AM; Pichler, M; Sokolova, O; Naumann, M; Mitterer, V; Pertschy, B; Bergler, H; Popper, H; Sattler, W; Haybaeck, J
Influence of eukaryotic translation initiation factor 6 on non-small cell lung cancer development and progression.
Eur J Cancer. 2018; 101(4):165-180
Doi: 10.1016/j.ejca.2018.07.001
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Klughammer, J; Kiesel, B; Roetzer, T; Fortelny, N; Nemc, A; Nenning, KH; Furtner, J; Sheffield, NC; Datlinger, P; Peter, N; Nowosielski, M; Augustin, M; Mischkulnig, M; Ströbel, T; Alpar, D; Ergüner, B; Senekowitsch, M; Moser, P; Freyschlag, CF; Kerschbaumer, J; Thomé, C; Grams, AE; Stockhammer, G; Kitzwoegerer, M; Oberndorfer, S; Marhold, F; Weis, S; Trenkler, J; Buchroithner, J; Pichler, J; Haybaeck, J; Krassnig, S; Mahdy Ali, K; von Campe, G; Payer, F; Sherif, C; Preiser, J; Hauser, T; Winkler, PA; Kleindienst, W; Würtz, F; Brandner-Kokalj, T; Stultschnig, M; Schweiger, S; Dieckmann, K; Preusser, M; Langs, G; Baumann, B; Knosp, E; Widhalm, G; Marosi, C; Hainfellner, JA; Woehrer, A; Bock, C
The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space.
Nat Med. 2018; 24(10):1611-1624
Doi: 10.1038/s41591-018-0156-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Short report/Letter
** Schatz, O; Zalaudek, I; Ghaffari, Tabrizi-Wizsy, N; Grechenig, C; Grinninger, P; Haas, A; Haybaeck, J; Hofmann-Wellenhof, R; Juch, H; Krassnig, S; Richtig, E; Lackner, A; Schwab, K; Wedrich, A; Weger, M; Schwab, C
Melanocytes, Organogenesis, and Angiogenesis: Evidence for More than a Pigment-Producing Capability of Melanocytes.
Cells Tissues Organs. 2018; 206(1-2):6-8
Doi: 10.1159/000495908
Web of Science
PubMed
FullText
FullText_MUG
Case Report
** Opriessnig, P; Silbernagel, G; Krassnig, S; Reishofer, G
Magnetic resonance microscopy diffusion tensor imaging of collagen fibre bundles stabilizing an atherosclerotic plaque of the common carotid artery.
Eur Heart J. 2018; 39(35): 3337-3337.
Doi: 10.1093/eurheartj/ehy146
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Bracic, S; Krassnig, S; Gantenbein, N; Mangge, H; Gruber, HJ; Haybaeck, J
eIF3p110 expression is elevated in thyroid cancer
VIRCHOWS ARCH. 2018; 473: S103-S103.
[Poster]
Web of Science
** Golob-Schwarzl, N; Wodlej, C; Kleinegger, F; Toeglhofer, AM; Krassnig, S; Thalhammer, M; Aigelsreiter, A; Hayback, J
Eukaryotic Translation Initiation Factors Might Represent a Potential Therapeutic Target for Gallbladder Cancer
ONCOL RES TREAT. 2018; 41: 68-68.-33. Deutscher Krebs Kongress; FEB 21-24, 2018; Berlin, GERMANY.
[Poster]
Web of Science
** Orthmann, A; Krassnig, S; Jodicke, A; Linnebacher, M; Silvestri, A; Regenbrecht, C; Fichtner, I; Hoffmann, J
New preclinical models for neuro-oncology: Integrating data from PD3D models and orthotopic xenografts
ONCOL RES TREAT. 2018; 41: 179-179.-Deutscher Krebskongress; FEB 21-24, 2018; Berlin, GERMANY.
[Poster]
Web of Science
** Wodlej, C; Krassnig, S; Golob-Schwarzl, N; Kleinegger, F; Toeglhofer, AM; Sygulla, S; Singer, G; Till, H; Izycka-Swieszewska, E; Czapiewski, P; Hayback, J
The Role of Eukaryotic Translation Initiation Factors as Potential Targets in Neuroblastoma
ONCOL RES TREAT. 2018; 41: 131-131.-33. Deutscher Krebs Kongress; FEB, 21-24, 2018; Berlin, GERMANY.
[Poster]
Web of Science
2017
Full paper/article (Journal)
** Golob-Schwarzl, N; Krassnig, S; Toeglhofer, AM; Park, YN; Gogg-Kamerer, M; Vierlinger, K; Schröder, F; Rhee, H; Schicho, R; Fickert, P; Haybaeck, J
New liver cancer biomarkers: PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors.
Eur J Cancer. 2017; 83(60):56-70
Doi: 10.1016/j.ejca.2017.06.003
Web of Science
PubMed
FullText
FullText_MUG
** Golob-Schwarzl, N; Schweiger, C; Koller, C; Krassnig, S; Gogg-Kamerer, M; Gantenbein, N; Toeglhofer, AM; Wodlej, C; Bergler, H; Pertschy, B; Uranitsch, S; Holter, M; El-Heliebi, A; Fuchs, J; Punschart, A; Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Reinhard, C; Regenbrecht, C; Schicho, R; Fickert, P; Lax, S; Haybaeck, J
Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6.
Oncotarget. 2017; 8(60):101224-101243
Doi: 10.18632/oncotarget.20642
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Golob-Schwarzl, N; Koller, C; Krassnig, S; Gogg-Kamerer, M; Gantenbein, N; Bergler, H; Pertschy, B; Uranitsch, S; Lackner, K; Puntschart, A; Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Reinhard, C; Schicho, R; Fickert, P; Lax, S; Haybaeck, J
Translation initiation separates low and high grade colon and rectum carcinoma
EUR J CANCER. 2017; 72: S57-S57.-ECCO European Cancer Congress; JAN 27-30, 2017; Amsterdam, NETHERLANDS.
Doi: 10.1016/S0959-8049(17)30267-8
[Oral Communication]
Web of Science
FullText
FullText_MUG
** Golob-Schwarzl, N; Koller, C; Krassnig, S; Gogg-Kammerer, M; Gantenbein, N; Bergler, H; Pertschy, B; Uranitsch, S; Holter, M; El-Heliebi, A; Fuchs, J; Punschart, A; Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Reinhard, C; Schicho, R; Fickert, P; Lax, S; Haybaeck, J
Translation initiation separates low and high grade and colon and rectum carcinoma
VIRCHOWS ARCH. 2017; 471: S167-S167.
[Poster]
Web of Science
** Golob-Schwarzl, N; Krassnig, S; Park, Y; Gogg-Kamerer, M; Wodlej, C; Vierlinger, K; Schroeder, F; Rhee, H; Schicho, R; Fickert, P; Haybaeck, J
PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors as new biomarkers in liver cancer
VIRCHOWS ARCH. 2017; 471: S164-S164.
[Poster]
Web of Science
** Kleinegger, F; Golob-Schwarzl, N; Toeglhofer, AM; Baran, P; Krassnig, S; Niedrist, T; Speicher, I; Rinner, B; Thalhammer, M; Aigelsreiter, A; Lackner, C; Scheller, J; Rose-John, S; Fickert, P; Haybaeck, J
Interleukin-6 Receptor influences cholangiocarcinoma progression
VIRCHOWS ARCH. 2017; 471: S325-S326.-29th European Congress of Pathology; SEP 2-6, 2017; Amsterdam, The Netherlands.
[Poster]
Web of Science
** Krassnig, S; Orthmann, A; Toeglhofer, AM; Wohlrab, C; Golob-Schwarzl, N; Wodlej, C; Pennauer, M; Raicht, A; Ali, KM; von Campe, G; Gogg-Kamerer, M; Logi, M; Sygulla, S; Hoffmann, J; Weis, S; Benesch, M; Haybaeck, J
Eukaryotic initiation factors might not only represent novel targets for glioma therapies but might also monitor drug effectiveness
VIRCHOWS ARCH. 2017; 471: S46-S46.
[Oral Communication]
Web of Science
** Toeglhofer, AM; Krassnig, S; Golob-Schwarzl, N; Wodlej, C; Birkl, C; Kalev, O; Leoni, M; Flunkert, S; Hutter-Paier, B; Weis, S; Haybaeck, J
Eukaryotic initiation factors are altered in Alzheimer's disease
VIRCHOWS ARCH. 2017; 471: S218-S219.
[Poster]
Web of Science
2016
Abstract (Journal)
** Orthmann, A; Hoffmann, A; Ernst, C; Golob-Schwarzl, N; Krassnig, S; Haybaeck, J; Jodicke, A; Kuhn, S; Linnebacher, M; Fichtner, I; Hoffmann, J
Therapeutic response to chemotherapeutic drugs of glioma-PDX and correlation to common mutations identified by panel sequencing
ONCOL RES TREAT. 2016; 39: 160-160.
[Oral Communication]
Web of Science
2015
Full paper/article (Journal)
** Krassnig, S; Schweinzer, C; Taub, N; Havas, D; Auer, E; Flunkert, S; Schreibmayer, W; Hutter-Paier, B; Windisch, M
Influence of Lentiviral β-Synuclein Overexpression in the Hippocampus of a Transgenic Mouse Model of Alzheimer's Disease on Amyloid Precursor Protein Metabolism and Pathology.
Neurodegener Dis. 2015; 15(4):243-257
Doi: 10.1159/000430952
Web of Science
PubMed
FullText
FullText_MUG
Abstract (Journal)
** Ernst, C; Krassnig, S; Golob-Schwarzl, N; Asslaber, M; Raicht, A; Lederer, E; Spilka, R; Von Campe, G; Orthmann, A; Hoffmann, J; Weis, S; Benesch, M; Haybaeck, J
Eukaryotic initiation factors and their contribution to gliomas might be relevant for the development of new therapies
VIRCHOWS ARCH. . 2015; 467: S40-S40.
[Oral Communication]
Web of Science
** Smolle, E; Krassnig, S; Gantenbein, N; Spindelböck, W; Sipos, B; Hoffmeister, M; Kump, P; Thalhammer, M; Lipp, R; Haybäck, J
Eukaryotic Translation Initiation Factors in Gastroenteropancreatic Neuroendocrine Tumors - A TMA based Study.
Wiener Klinische Wochenschrift. 2015; 127(17-18):724--Jahrestagung der Österreichischen Gesellschaft für Innere Medizin, ÖGIM; SEP 24-26, 2015; Salzburg Congress, Salzburg, AUSTRIA.
[Poster]
Web of Science
** Smolle, E; Krassnig, S; Gantenbein, N; Spindelböck, W; Sipos, B; Hoffmeister, M; Kump, P; Thalhammer, M; Lipp, R; Haybäck, J
Eukaryotic translation initiation factors in gastroenteropancreatic neuroendocrine tumours: ATMA based analysis
VIRCHOWS ARCH. 2015; 467: S129-S130.
[Poster]
Web of Science